Women's Health Weekly
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Women's Health Weekly
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Breast Cancer Therapy
Data on breast cancer therapy discussed by researchers at University of Surrey
July 31st, 2008
Current study results from the report, 'Mechanisms and strategies to overcome chemotherapy resistance in metastatic breast cancer,' have been published. According to recent research from Guildford, the United Kingdom, "Resistance to chemotherapeutic agents is a significant issue in the management of patients with breast cancer. Anthracyclines, although first used over 30 years ago, are still part of the standard chemotherapy for this disease." "Subsequently, the taxanes heralded a new era in chemotherapy and have been used extensively in the treatment of metastatic breast cancer. Unfortunately, along with other constituents of combination chemotherapy for metastatic...
Source: Women's Health Weekly (2008-07-31)
|
